Invention Grant
- Patent Title: Neisseria meningitidis composition and methods thereof
-
Application No.: US15630147Application Date: 2017-06-22
-
Publication No.: US10196429B2Publication Date: 2019-02-05
- Inventor: Annaliesa Sybil Anderson , Susan Kay Hoiseth , Kathrin Ute Jansen , Justin Keith Moran , Mark E. Ruppen
- Applicant: PFIZER INC.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Anna C. Chau
- Main IPC: A61K39/095
- IPC: A61K39/095 ; C07K14/22
Abstract:
In one aspect, the invention relates to a non-lipidated and non-pyruvylated Neisseria meningitidis serogroup B subfamily A A12 polypeptide. In another aspect, the invention relates to an immunogenic composition including an isolated non-lipidated, non-pyruvylated ORF2086 polypeptide from Neisseria meningitidis serogroup B, and at least one conjugated capsular saccharide from a meningococcal serogroup.
Public/Granted literature
- US20180371030A1 NEISSERIA MENINGITIDIS COMPOSITION AND METHODS THEREOF Public/Granted day:2018-12-27
Information query
